Categories
Blog

Navigating the Regulatory Seas: How Experts Ensure Your Medical Devices Set Sail Smoothly

medical device regulation requirements

Introduction 

In the ever-changing world of medical device manufacturing, ensuring your product complies with regulations is akin to navigating stormy seas. The safety of patients, the assurance of quality, and the complexities of compliance weigh heavily on manufacturers. This article sheds light on the challenges faced and how expert navigators—regulatory consultants—play a pivotal role in ensuring your medical device not only sails through but sets a course for success.

Here are the key points regarding medical device regulations in Canada:

  1. Medical Device Licensing: Health Canada requires all medical devices to be licensed before they can be sold in the country. There are different classes of medical devices, and the requirements for licensing vary depending on the class. Class I devices, which pose the lowest risk, generally require a Medical Device Establishment License (MDEL), while Class II, III, and IV devices require a device license.

  2. Device Classification: Medical devices are classified into four classes (Class I, II, III, and IV) based on their potential risk. Class I devices have the lowest risk, while Class IV devices pose the highest risk. The classification of a device determines the level of scrutiny and requirements for licensing.

  3. Quality Management Systems: Manufacturers are often required to have a certified Quality Management System (QMS) in place, such as ISO 13485, which demonstrates their ability to produce medical devices consistently and meet regulatory requirements.

  4. Labeling and Language Requirements: Medical device labeling must be in both English and French, as Canada is a bilingual country. Labels must include essential information about the device, including its intended use, precautions, and directions for use.

  5. Post-Market Surveillance: Manufacturers are obligated to monitor the performance of their devices once they are on the market. This includes reporting adverse events, conducting recalls if necessary, and addressing safety concerns.

  6. Unique Device Identification (UDI): Health Canada introduced a UDI system to enhance the traceability of medical devices. Manufacturers are required to label their devices with a unique identifier, allowing for easier tracking and recall if safety issues arise.

Understanding the Regulatory Maze

Medical device requirements are like a vast, intricate map; understanding them is no small feat. Some standards and guidelines can make even the most seasoned manufacturer feel lost at sea from the design phase to production.

The challenges of medical device requirements and compliance

  1. Ever-Changing Tides: Regulatory requirements are not stagnant; they are constantly shifting and evolving. Keeping up with these changes and understanding how they apply to your specific device is a daunting challenge.
  2. Diverse Global Standards: To market your device internationally, you must navigate diverse regulations. Each country has its requirements, making compliance a multifaceted challenge.
  3. Complex Documentation: The paperwork required for regulatory submissions is not for the faint of heart. Ensuring every document is accurate, complete, and submitted on time adds another layer of complexity.

What role will our medical device regulatory consultants fill?

  1. Seasoned Seafarers: Regulatory consultants are like seasoned captains who have sailed these waters before. Their experience and expertise help manufacturers make sense of the maze of regulations, providing practical and invaluable guidance.
  2. Customized Navigation: Every medical device and its challenges regarding compliance are unique. Consultants tailor their strategies, ensuring your compliance journey is specifically designed for your product and preventing common pitfalls.
  3. Mitigating Compliance Challenges: Consultants don’t just help you navigate; they help you anticipate challenges. By identifying potential issues early on, they assist in making necessary course corrections, preventing refusals, and ensuring a smoother voyage.

How our Regulatory Consultants help us to prevent refusals

  1. Early Warning Systems: Consultants act as early warning systems, identifying compliance challenges in the initial stages of development. This proactive approach allows manufacturers to make necessary adjustments, preventing refusals before they become possible.
  2. Comprehensive Risk Assessment: Consultants conduct thorough risk assessments, mapping potential obstacles. By understanding these risks, manufacturers can take preventive measures, significantly reducing the chances of refusals.

Conclusion 

In the unpredictable seas of medical device regulations, having a seasoned navigator by your side can make all the difference. Regulatory consultants provide the expertise to navigate the challenges, ensuring your product sails smoothly through approval. By investing in their knowledge, manufacturers can meet compliance requirements and innovate confidently, ultimately bringing safe, high-quality medical devices to the market. Safe travels!

Our experts at Quality Smart Solutions are here to help and offer medical device-related regulatory advice and support on successfully securing your medical device license.  We can help you by responding to potential information requests, keeping your license updated, and reviewing your device labels (510k Medical Device RegistrationFacility Registration & FURLSIVD Device Registration, and SaMD Classification

Categories
Blog

510k Submission Guidance: Unpacking the 510k Requirements

510k Submissions

Introduction

In the world of medical devices, ensuring patient safety and efficacy is paramount. The 510(k) submission process is a critical step for manufacturers seeking clearance from the U.S. Food and Drug Administration (FDA) to market their devices. This process can be complex, but it plays a pivotal role in bringing innovative medical devices to market. In this article, we’ll unpack the 510(k) submission requirements, helping manufacturers navigate the regulatory landscape with confidence.

Understanding the 510(k) Submission

The 510(k) submission is named after Section 510(k) of the Federal Food, Drug, and Cosmetic Act, which requires device manufacturers to notify the FDA at least 90 days in advance before introducing a new medical device into commercial distribution. The purpose of this notification is to demonstrate that the device is “substantially equivalent” to a legally marketed device (often referred to as a predicate device) in terms of safety and effectiveness.

Here’s a step-by-step guide to help manufacturers understand and meet the 510(k) submission requirements:

  1. Identify the Appropriate Predicate Device: The first and most crucial step is identifying a suitable predicate device. This is a device already on the market that is similar to the one you want to submit for clearance. The FDA uses the predicate device as a benchmark to assess the substantial equivalence of your device.

  2. Determine Substantial Equivalence: Your device must be substantially equivalent to the predicate device in terms of intended use, technological characteristics, and performance data. Any differences must be justified and explained thoroughly in the submission.

  3. Compile a Comprehensive 510(k) Submission: Prepare a thorough submission that includes:

    • A cover letter: This summarizes the submission and states its purpose.
    • Device description: Provide detailed information about your device, including its intended use, design, materials, and manufacturing processes.
    • Comparison to the predicate device: Highlight the similarities and differences between your device and the predicate device.
    • Performance data: Include test results, clinical data, and any other relevant information demonstrating the safety and effectiveness of your device.
    • Proposed labeling: Submit labeling, including user manuals and package inserts.
    • Biocompatibility data: Detail how your device interacts with the human body and any biocompatibility testing results.
    • Risk analysis: Identify potential risks associated with your device and how you plan to mitigate them.
  4. Compile Quality System Information: Include documentation of your Quality System Regulation (QSR) compliance. This should cover your manufacturing processes, quality control procedures, and any relevant certifications.

  5. Prepare an FDA Application: Register your establishment with the FDA and submit your 510(k) application online through the FDA’s electronic submission gateway.

  6. Wait for FDA Feedback: Once submitted, the FDA will review your 510(k) submission. They may provide feedback or request additional information. Respond promptly and thoroughly to any requests to expedite the review process.

  7. FDA Clearance: If your submission is successful, the FDA will issue a clearance letter. This means you can market your device in the United States.

Conclusion

Navigating the 510(k) submission process can be challenging, but it’s a crucial step in bringing your medical device to market. Properly understanding and meeting the 510(k) requirements, from identifying a suitable predicate device to compiling a comprehensive submission, is essential for success. Collaboration with regulatory experts and consultants who are well-versed in the FDA’s processes can be invaluable during this journey. By following these guidelines and investing in due diligence, you can increase your chances of obtaining FDA clearance and contributing to the advancement of medical technology while ensuring patient safety.

To learn when and how to file your 510k submissions click here:

Our experts at Quality Smart Solutions are here to help and offer medical device-related regulatory advice and support on successfully securing your medical device license.  We can help you by responding to potential information requests, keeping your license updated, and reviewing your device labels (510k Medical Device RegistrationFacility Registration & FURLSIVD Device Registration, and SaMD Classification

Categories
Blog

Navigating French Language Labeling Requirements in Canada: A Guide for Food Manufacturers

Navigating French Language Labeling Requirements in Canada: A Guide for Food ManufacturersIntroduction:

As a food manufacturer in Canada, ensuring that your product labels comply with Health Canada’s regulations is crucial for successful market entry and consumer safety. For businesses looking to distribute food products in Canada, one essential aspect is adherence to bilingual labeling requirements, notably including French alongside English on product labels. In this blog, we’ll explore common questions about French label requirements in Canada and how food manufacturers can ensure compliance with Health Canada’s regulations.

Food Labeling Regulations and Food Label French Translation in Canada

  • Mandatory Bilingual Content:

In Canada, food labeling must be bilingual, meaning it should be in French and English to cater to the bilingual population. This includes provinces where French is the official language, such as Quebec and certain parts of New Brunswick.

  • Essential Information:

Labels must include essential information such as the product name, ingredient list, nutrition facts, allergens, and mandatory statements, where applicable. All this information must be available in both official languages.

Common food labeling mistakes to avoid in Canada

  • Incorrect Translation:

One of the most common mistakes is the incorrect translation of labeling information. It’s crucial to ensure that translations into French are accurate and compliant with Canadian standards.

  • Inadequate Font Size:

The font size used for French information must be large enough to be legible. Errors occur when the font size is too small to meet readability requirements.

  • Omission of Allergens:

It is a severe error to mention common allergens in French. Consumers must be clearly and comprehensibly informed about allergens in products.

  • Failure to Comply with Standards:

Non-compliance with French labeling regulations can lead to penalties, product recalls, and financial losses. Staying informed about constantly evolving regulatory requirements is essential.

FAQs on French Labeling Requirements in Canada

 

1. Do I need to provide French labeling for my food products in Canada?

  • Yes, if you’re a food manufacturer selling products in Canada, it’s mandatory to have bilingual labels. French labeling is required alongside English to cater to the country’s bilingual population.

2. What information should be included in the French portion of the label?

  • The French portion of the label should contain all the necessary information, such as product names, ingredient lists, nutrition facts, allergen information, and any mandatory statements, all presented accurately in French.

3. Can I use a bilingual label with English and French side by side?

  • Yes, bilingual labels with both English and French text are acceptable. However, ensuring that all required information is present in both languages and meets legibility requirements is essential.

Product Name and Ingredient List

1. Do I need to translate the product name into French?

  • Absolutely. If your product name is in English, it should be accurately translated into French. This translation should reflect the product’s nature.

2. Should I provide the ingredient list in French as well?

  • Yes, the ingredient list must be provided in French, including accurate translations of ingredient names to ensure clarity for French-speaking consumers.

Nutrition Facts and Allergen Information

1. How do I present nutrition facts in French?

  • Nutrition facts should be presented in English and French, with the French text close to English and designed for easy readability.

2. What about allergen information in French?

  • Any allergen information, including “Contains” statements, must be presented in French if it appears in English on the label. Ensure that these translations are accurate and prominently displayed.

Font Size and Legibility

1. Are there specific font size and legibility requirements for the French text?

  • Yes, Health Canada mandates that the French text be easily readable. Font size requirements vary based on the size of your packaging. Additionally, ensure that the text contrasts sufficiently with the background for clear visibility.

Conclusion

Compliance with French label requirements in Canada is a regulatory necessity and an essential step in building consumer trust. Non-compliance can lead to consequences such as product recalls and legal issues. To ensure your food labels align with Health Canada’s regulations, consult their guidance and consider seeking legal advice when needed. By adhering to these bilingual labeling requirements, you can confidently introduce your food products to the Canadian market and cater to its diverse, bilingual population.

At Quality Smart Solutions, we have a team of experts who are skilled in both Canadian and USA food labelling compliance. We offer several solutions to meet your needs and understand the importance of french translation food labelling. 

Categories
Blog

Why is it crucial to avoid FDA Warning Letters for dietary supplements and health products?

The Implications of FDA Warning Letters

 

As a business owner operating in dietary supplements and health products, you are undoubtedly aware of the ever-evolving regulatory landscape. Ensuring that your products meet the stringent requirements set forth by the U.S. Food and Drug Administration (FDA) is not merely a matter of legal obligation; it’s imperative for your brand’s success and consumer safety. This article will explore the importance of steering clear of FDA Warning Letters and what they signify for your business.

The FDA’s Role in Ensuring Product Safety

The FDA plays a pivotal role in safeguarding public health by overseeing the safety and efficacy of various products, including dietary supplements and health products. These regulatory guidelines are designed to protect consumers from potential health hazards and misleading claims. For business owners, compliance with these guidelines is a legal requirement and a responsibility towards their customers.

FDA Warning Letters: A Red Flag

Receiving an FDA Warning Letter indicates that your business needs to comply with federal regulations. It serves as an official communication from the FDA to notify you of significant violations that require immediate attention. Warning Letters are issued when the FDA finds misbranded products, unapproved health claims, adulteration, or non-compliance with Current Good Manufacturing Practices (cGMPs).

The Implications of FDA Warning Letters

  1. Reputation Damage: Perhaps the most immediate and damaging consequence of receiving a Warning Letter is the negative impact on your brand’s reputation. Consumers often view these letters as red flags, leading to decreased trust in your products and company.
  2. Market Access Challenges: Non-compliance can limit your product’s market access or lead to development recalls, resulting in significant financial losses.
  3. Legal Consequences: Ignoring or inadequately addressing Warning Letters can escalate the situation, potentially leading to legal actions, including product seizures, injunctions, and fines.
  4. Resource Drain: Rectifying compliance issues can be time-consuming and costly, diverting resources from business growth and development.
  5. SEO: Resources and FDA pages always appear on the first page of Google due to their high domain authority. Therefore, if you are given a warning letter whenever someone Google your company’s name, they’ll see you failed to be compliant at some time and hurt your image.

The Path to Compliance

To avoid the pitfalls associated with FDA Warning Letters, proactive measures are paramount:

  1. Stay Informed: Regularly monitor FDA guidance and regulations related to your products. The FDA frequently updates guidelines, and staying informed is critical.
  2. Invest in Quality Control: Adhering to cGMPs is essential for ensuring the quality and safety of your products. Implement robust quality control measures to maintain compliance.
  3. Labeling and Marketing Claims: Ensure your product labels and marketing materials adhere to FDA guidelines. Avoid making unapproved health claims or using misleading language.
  4. Documentation: Maintain meticulous records of your products’ formulation, testing, and distribution to demonstrate compliance in case of an audit.
  5. Seek Expert Guidance: Engage regulatory experts or consultants specializing in FDA compliance. Their expertise can help you navigate the complexities of regulatory requirements effectively.

Conclusion

Maintaining FDA compliance in the competitive landscape of dietary supplements and health products is not just about legal obligations; it’s a strategic imperative. Avoiding FDA Warning Letters is vital for preserving your brand’s reputation, ensuring consumer safety, and securing your market presence. By prioritizing compliance, you protect your business and contribute to enhancing public health through safe and effective products.

Our Regulatory experts can help you ensure compliance with your medical devicesfood/beveragedietary supplements, cosmetics with MoCRA Regulations, and drug products including all FDA Facility Registration

Categories
Blog

Everything businesses should know about submitting a 30-Day Pre-Market Notification and Structure-Function Claims

Title: Everything Businesses Should Know About Submitting a 30-Day Pre-Market Notification and Structure-Function Claim for Dietary SupplementsIn dietary supplements, navigating the intricate regulatory landscape is a challenging yet indispensable aspect of launching your product. Submitting a 30-day Pre-Market Notification and Structure-Function Claim to the U.S. Food and Drug Administration (FDA) is a pivotal regulatory requirement. This notification must be submitted at least 30 days before introducing your dietary supplement to the market. This article delves into this process’s essential facets, including steps awaiting FDA confirmation and regulatory solutions for label review, facility registration, and compliance with the Foreign Supplier Verification Program (FSVP) Import Agent requirement.

Understanding the 30-Day Pre-Market Notification

The 30-Day Pre-Market Notification is a regulatory mandate meticulously enforced by the FDA for all novel dietary supplement products entering the market. This notification serves as a conduit for the FDA to scrutinize and assess the product’s safety and adherence to labeling requirements. The primary objective is to guarantee the security of these products for consumers, coupled with the veracity of the labeling regarding ingredients and intended use.

Steps for Submitting a 30-Day Pre-Market Notification

  1. Determining Product Eligibility: Not all dietary supplements necessitate a 30-day pre-market notification. In specific cases, exemptions are available for products containing ingredients marketed in the United States before October 15, 1994, or products meeting particular criteria. Engaging regulatory experts for definitive clarification concerning your product’s eligibility is imperative.
  2. Compilation of Essential Information: Before initiation, assemble all requisite data, encompassing a comprehensive ingredient list, dosage instructions, intended use, and any structure-function claims you intend to assert.
  3. Preparation of the Notification: Utilize the FDA’s Dietary Supplement Registration and Notification System (DSN) to prepare and submit your notification. This online platform streamlines the process, ensuring the provision of all necessary details.
  4. Payment of Applicable Fees: The FDA typically charges a notification submission fee. Scrutinize the current fee schedule and proceed with the requisite amount.
  5. Submission of the Notification: Submit your notification via the DSN portal after the preparation. Expect an acknowledgment from the FDA confirming receipt of your request.

Waiting for FDA Confirmation

Upon submitting your 30-day pre-market notification, the FDA will engage in an extensive review process to ascertain compliance with safety and labeling requirements. This procedure may extend to 75 days, encompassing the obligatory 30-day waiting period. During this interval, the FDA might request supplementary information or clarifications regarding your product. It is imperative to exercise patience while awaiting the FDA’s confirmation before embarking on marketing and distribution endeavors for your dietary supplement. A premature product launch can culminate in regulatory complications and potentially tarnish the reputation of your business.

Regulatory Solutions for Label Review, Facility Registration, and FSVP Import Agent

  1. Label Review: Ensuring strict adherence to FDA labeling regulations for dietary supplements is imperative. Consider engaging regulatory experts or consultants with specialized knowledge of dietary supplements to review your labels for compliance. This prudent step serves as a bulwark against costly label-related issues in the future.
  2. Facility Registration: Manufacturers and distributors of dietary supplements must meticulously register their facilities with the FDA. Ensure comprehensive facility registration to obviate regulatory hurdles. Continuously update your registration information to maintain compliance.
  3. FSVP Import Agent: If you’re involved in importing dietary supplements into the U.S., securing a proficient Foreign Supplier Verification Program (FSVP) Import Agent is paramount. The designated agent is tasked with ensuring foreign suppliers align with FDA requirements. Selecting a knowledgeable FSVP Import Agent is pivotal to complying with this crucial regulation.

In conclusion, submitting a 30-day pre-market notification and adhering to dietary supplement regulations are essential undertakings for businesses in this area. By comprehending the intricacies of the process, patiently awaiting FDA confirmation, and proactively addressing labeling, facility registration, and FSVP Import Agent prerequisites, businesses can navigate the regulatory terrain adeptly, thereby facilitating the introduction of safe and compliant products into the market. Compliance ensures consumer safety and contributes to dietary supplement enterprises’ enduring success and esteem.

Learn about the impact of the pre-market notification and structure-function claims on the 510k medical device process.

We can help you create the best structure-function claims to propel your business to new heights. Learn about the pre-market notification and structure-function claim process for food and dietary supplements.

Categories
News

Health Canada’s Notice Enables the Use of L-alpha Glycerylphosphorylcholine in Supplemented Food

Health Canada Approves Alpha GPC in Foods

Discover Health Canada's latest approval of L-alpha-glycerylphosphorylcholine in supplemented foods. Learn about regulatory changes, safety assessments, and conditions for use.On September 20, 2023, Health Canada approved the use of L-alpha-glycerylphosphorylcholine (alpha GPC) as a supplement in foods. This decision followed a thorough safety review by Health Canada’s Food Directorate.

How Health Canada Administers Foods and Food Supplements

Health Canada ensures food and drug safety is maintained in Canada. They set the rules for food safety under the Food and Drugs Act. In July 2022, they introduced regulations specifically for foods with supplements. These regulations outline the requirements for adding supplements to foods.

Alpha GPC Safety Assessment

Health Canada conducted a detailed safety review of alpha GPC, looking at its chemistry, nutrition, and potential health risks. The review confirmed that alpha GPC is safe to use as a choline supplement in foods as long as it meets labeling and maximum usage guidelines.

Public Feedback

Health Canada opened a public comment period from April 17 to July 1, 2023, on its proposal to allow alpha GPC in foods. No new scientific information or objections were submitted, so the original safety conclusions remained unchanged.

Enforcement and Implementation

The change allowing alpha GPC in foods took effect on September 20, 2023. The Canadian Food Inspection Agency will enforce these new regulations to ensure compliance.

Access to Supplemental Ingredient Information

Health Canada provides a list of all approved supplemental ingredients, including alpha GPC, on their website. This list outlines which foods can contain these ingredients, the maximum allowed amounts, and any required safety labels.

Guidance for Food Manufacturers

Health Canada has also published a guidance document for food manufacturers. This document explains how to comply with the regulations, including labeling and safety standards for supplemented foods.

Background on the Health Canada Regulatory Authority

Under the Food and Drugs Act, Health Canada is authorized to establish requirements and conditions for foods available in the Canadian market. To facilitate this, the “Supplemented Foods Regulations,” which amended the Food and Drug Regulations and the Cannabis Regulations, were introduced on July 21, 2022. These regulations define the specific regulatory requirements applicable to supplemented foods, outlined within the Food and Drug Regulations (Part B, Division 29, and other relevant provisions). Additionally, Subsection 102(2) of the Cannabis Regulations plays a role in overseeing these regulations.

The permitted categories of supplemented foods and the supplemental ingredients, along with their conditions of use, are detailed in the “List of Permitted Supplemented Food Categories” and the “List of Permitted Supplemental Ingredients,” respectively. These lists are incorporated by reference into the Food and Drug Regulations and are regularly updated on the Canada.ca website.

Safety Assessment of L-alpha Glycerylphosphorylcholine

The decision to enable the use of L-alpha-glycerylphosphorylcholine in supplemented foods was grounded in a rigorous safety assessment conducted by Health Canada’s Food Directorate. This assessment encompassed various aspects, including chemistry, nutrition, microbiology, toxicology, and allergenicity. The evaluation concluded that the available information unequivocally supports the safe use of L-alpha-glycerylphosphorylcholine as a source of supplemental choline in supplemented foods, provided that its usage levels do not exceed the previously established maximum levels for choline and that all labeling requirements are met.

Notification: Summary of Comments and Health Canada’s Responses

As mentioned earlier, Health Canada received no comments or objections regarding the proposal. This lack of feedback reaffirms the department’s confidence in the safety assessment of L-alpha-glycerylphosphorylcholine.

Implementation and Enforcement

As of September 20, 2023, the modification allowing the use of L-alpha-glycerylphosphorylcholine in supplemented foods came into effect. This change was published in the “List of Permitted Supplemental Ingredients.” It is crucial to note that the Canadian Food Inspection Agency is responsible for enforcing the Food and Drugs Act and its associated regulations, particularly concerning foods.

Health Canada’s decision to use L-alpha-glycerylphosphorylcholine in supplemented foods underscores the department’s commitment to ensuring the safety and quality of food products available to Canadians.

This regulatory change aligns with Health Canada’s ongoing efforts to provide consumers access to safe and beneficial dietary supplements while maintaining stringent safety standards. As this modification takes effect, consumers and food manufacturers can expect to see L-alpha-glycerylphosphorylcholine as an approved source of supplemental choline in a range of supplemented food products across Canada.

Accessing the list of Supplemental Ingredients and their conditions

This document is a valuable resource for those interested in exploring the List of Permitted Supplemental Ingredients and understanding their use conditions. It provides detailed information about the supplemental ingredients authorized for addition to supplemented foods. It outlines the specific requirements governing their usage. These conditions encompass:

  1. Food Category: This indicates the type of food to which the supplemental ingredient may be added.
  2. Maximum Amount and Units per Serving: Specifies the highest quantity of the supplemental ingredient that can be included in a serving of food, along with the units of measurement applicable to the stated serving size.
  3. Cautionary Statements: Identifies any mandatory cautionary statements that must be included on the product label for each supplemental ingredient and establishes the threshold level at which these statements become obligatory.
  4. Additional Conditions of Use and Labeling Requirements: Outlines any other conditions or labeling requirements on using the supplemental ingredient.

It is essential to note that certain ingredients are strictly prohibited from being added to supplemented foods at any level. Furthermore, additional restrictions may apply to including specific supplemental ingredients in food products.

Guidance Document for Supplemented Foods Regulations

For those seeking comprehensive guidance on supplemented foods regulations, including detailed information on permitted supplemental ingredients and their conditions of use, Health Canada has provided a dedicated resource known as the “Guidance Document for Supplemented Foods Regulations.”

This guidance document offers a wealth of information, encompassing:

  1. Supplemental Ingredient Details: Comprehensive information on all permitted supplemental ingredients, their respective conditions of use, and other essential details.
  2. Regulatory Compliance: Guidance on ensuring compliance with the regulations governing supplemented foods, including labeling requirements and safety standards.
  3. Amendment Process: An explanation of the procedures and requirements for proposing and adding new supplemental ingredients to the List of Permitted Supplemental Ingredients.

Accessing the list of Supplemental Ingredients and their conditions

Discover Health Canada's latest approval of L-alpha-glycerylphosphorylcholine in supplemented foods. Learn about regulatory changes, safety assessments, and conditions for use.This document is valuable for those interested in exploring the List of Permitted Supplemental Ingredients and understanding their use conditions. It provides detailed information about the supplemental ingredients authorized for addition to supplemented foods. It outlines the specific requirements governing their usage. These conditions encompass:

  1. Food Category: This indicates the type of food to which the supplemental ingredient may be added.
  2. Maximum Amount and Units per Serving: Specifies the highest quantity of the supplemental ingredient that can be included in a serving of food, along with the units of measurement applicable to the stated serving size.
  3. Cautionary Statements: Identifies any mandatory cautionary statements that must be included on the product label for each supplemental ingredient and establishes the threshold level at which these statements become obligatory.
  4. Additional Conditions of Use and Labeling Requirements: Outlines any other conditions or labeling requirements on using the supplemental ingredient.

It is essential to note that certain ingredients are strictly prohibited from being added to supplemented foods at any level. Furthermore, additional restrictions may apply to including specific supplemental ingredients in food products.

Guidance Document for Supplemented Foods Regulations

For those seeking comprehensive guidance on supplemented foods regulations, including detailed information on permitted supplemental ingredients and their conditions of use, Health Canada has provided a dedicated resource known as the “Guidance Document for Supplemented Foods Regulations.”

This guidance document offers a wealth of information, encompassing

  1. Supplemental Ingredient Details: Comprehensive information on all permitted supplemental ingredients, their respective conditions of use, and other essential details
  2. Regulatory Compliance: Guidance on ensuring compliance with the regulations governing supplemented foods, including labeling requirements and safety standards
  3. Amendment Process: An explanation of the procedures and requirements for proposing and adding new supplemental ingredients to the List of Permitted Supplemental Ingredients

By consulting this guidance document, stakeholders, including food manufacturers, can better understand the regulatory landscape for supplemented foods in Canada. It serves as a valuable reference for newcomers and experienced industry professionals, facilitating compliance with Health Canada’s stringent standards and ensuring the safety and quality of supplemented food products in the Canadian market.

Health Canada’s commitment to transparency and safety in supplemented foods is underscored by the availability of these resources. Accessing the List of Permitted Supplemental Ingredients and the Guidance Document for Supplemented Foods Regulations empowers industry players and consumers with the knowledge and tools to navigate the regulatory landscape effectively and make informed decisions regarding supplemented food products.

Click here to learn about the Supplemented Facts Table Regulations.

How We Can Help 

At Quality Smart Solutions, we have the expertise needed to ensure your foods or food supplements comply with Health Canada. Navigating the complexities of this process can be challenging so our experienced and highly qualified team is here to help you achieve the best outcome for your success. Contact us today to discuss how we can support your business!

 

Categories
News

Navigating Cosmetic Product Regulations through FDA Recent MoCRA Update

Navigating Cosmetic Product Regulations through FDA Recent MoCRA UpdateIntroduction:

In response to the FDA’s recent draft guidance on the Registration and Listing of Cosmetic Product Facilities and Products, we’ve got some updates and insights that might interest you, especially if you’re in the cosmetic business.

First, nearly 50 public comments were submitted to the FDA regarding this draft guidance by the September 5, 2023 deadline. These comments covered various aspects, from concerns about the burden estimates to suggestions for making the whole process smoother and more transparent.

Let’s break down some of the key takeaways:

1. Burden Estimates: The FDA noted the public’s feedback and increased its burden estimates for certain reporting activities related to product listings. However, they didn’t tweak the estimates for tasks such as updating product labels or reporting severe adverse events. So, some things remain unchanged.

2. Confidentiality: If you were concerned about the confidentiality of the data you’d be submitting, the FDA referred to existing regulations. They pointed out that privacy and protection of trade secrets and commercially confidential information are covered by the Privacy Act of 1974 and FDA regulations (21 CFR part 20).

3. Deadlines: Unfortunately, if you were hoping for an extension of the December 29, 2023, deadlines for product listing and facility registration, there won’t be one. The FDA emphasized that these deadlines are mandated by law, so they’re set in stone.

Here’s a new term for FEI: Facility Establishment Identifier. This nifty little number is generated by the FDA and is used to identify your firm. You’ll need it when you’re submitting product listings and facility registrations.

If you’re wondering whether your company already has an FEI, here’s how to find out:

  • Request access to the FEI portal [link].
  • You’ll get an email with a password for the portal.
  • Log in and search for your company using its name and address.
  • If you need help finding an FEI for your company, you can request one by emailing feiportal@fda.hhs.gov. Just make sure you provide all the required information listed in the article.

Getting an FEI ensures your cosmetic business complies with the FDA’s regulations. So, if you still need one, we suggest getting on that pronto.

We hope this update helps you navigate the regulatory landscape more smoothly. If you have any more questions or need assistance, please reach out. Your compliance is essential, and we’re here to support your cosmetic business every step of the way.

Need help ensuring your cosmetic ingredients are safe for use? Get assistance with your U.S.A cosmetic product compliance from our consultants. 

Categories
Blog

Selling Your Food Products in the USA: A Guide for Food Business Owners

Selling Your Food Products in the USA: A Guide for Food Business OwnersIf you’re selling food products in the United States, understanding and complying with FDA regulations is non-negotiable. The Food and Drug Administration (FDA) has established rigorous requirements to ensure the safety and transparency of food products available to consumers. Here’s a practical guide tailored to food business owners on ensuring your food products meet the requirements for successful sales in the U.S.

1. Complying with FDA Food Label Requirements

Your food product’s label is more than just branding; it’s the first point of contact with your consumers. To ensure compliance with FDA food label requirements, here are some key considerations:

  • Nutrition Facts Panel: Your product label must feature a Nutrition Facts Panel prominently. This panel provides crucial information about the nutritional content of your product, empowering consumers to make informed choices.
  • Allergen Declaration: Clearly state any significant food allergens present in your product. This is essential for consumers with food allergies; non-compliance can have serious consequences.
  • Ingredient List: Provide a comprehensive ingredient list, arranging ingredients in descending order of predominance. Transparency here is vital for consumers with dietary restrictions or preferences.
  • Net Quantity Declaration: Accurately state the net quantity of your product. This helps consumers understand the amount they’re purchasing.

2. FDA Facility Registration and U.S. Agent

FDA facility registration is obligatory if your operations involve manufacturing, processing, packing, or storing food products. Here’s what you need to know:

  • Registration Requirement: Your food facility must be registered with the FDA. This legal requirement applies to domestic and foreign facilities involved in food-related activities.
  • U.S. Agent: For foreign facilities, designating a U.S. Agent is essential. Your U.S. Agent is a vital communication link between your facility and the FDA. They’ll receive FDA communications, inspection notices, and other official correspondence on your behalf.

3. Navigating the FSVP Import Agent Requirement Compliance

The Foreign Supplier Verification Program (FSVP) is a critical component if your business involves importing food into the United States. Here’s how to ensure your compliance:

  • Mandatory Program: FSVP is not optional; it’s compulsory for importers of food products. Its primary goal is to ensure that your foreign suppliers adhere to U.S. food safety standards.
  • Qualified FSVP Import Agent: Appoint a qualified FSVP Import Agent. This individual or entity is responsible for developing and implementing your FSVP plan. They’ll make sure the food you import aligns with FDA regulations.
  • Documentation and Verification: Keep meticulous records of your verification activities. This includes supplier assessments, food testing results, and audit reports. These records serve as tangible proof of your compliance with FSVP requirements.

Conclusion

Navigating the labyrinth of requirements for selling food products in the United States is a complex but essential task for food business owners. From meticulous food labeling to facility registration and FSVP compliance, your attention to detail ensures both the safety of consumers and the success of your business. Remember, consumers trust that the food they buy is safe and accurately labeled, making compliance with these regulations a cornerstone of your business’s reputation and prosperity.

We can provide FDA food label compliance, Nutrition Facts Panel creation and act as your FSVP Import Agent. We can also guide you through the entire FDA Facility Registration or FDA Facility Renewal process for domestic and foreign Food facilities.

Categories
Blog

Navigating Health Canada’s NPN Application Process: A Comprehensive Guide

NPN Application ProcessIntroduction: 

Health Canada’s Natural Products Number (NPN) application process is vital for manufacturers and distributors of natural health products (NHPs) in Canada. Obtaining an NPN is not only a regulatory requirement but also a testament to the safety and quality of your product. In this comprehensive guide, we will walk you through the NPN application process from start to finish, ensuring that you understand the steps, requirements, and critical considerations for a successful application. Let’s embark on this journey to compliance and consumer confidence.

Understanding the NPN: What is it? 

The Natural Product Number (NPN) is a unique identifier issued by Health Canada. It signifies that a natural health product has been reviewed and approved for sale in Canada. This approval indicates that the product meets specific safety, efficacy, and quality standards established by Health Canada.

Step 1: Determine Eligibility Before diving into the application process, it’s essential to determine whether your product qualifies as a natural health product (NHP) under Health Canada’s definition. NHPs include vitamins, minerals, herbal remedies, homeopathic and traditional medicines. Ensure your product fits this category before proceeding.

Step 2: Compile Essential Documentation. Gather all the necessary documentation to support your NPN application. This includes product labels, safety and efficacy data, ingredient information, and relevant research studies. Accuracy and completeness in this phase are crucial.

Step 3: Conduct a Thorough Product Classification. Classify your product under one of the following categories: non-prescription drugs, NHPs, or cosmetics. This step helps determine the regulatory pathway for your development.

Step 4: Determine the Appropriate Regulatory Path. Depending on the classification, you will follow either the NHP or Food and Drug Regulations. Ensure you choose the correct pathway, as each has unique requirements and guidelines.

Step 5: Prepare Your NPN Application. Compose your NPN application using Health Canada’s templates and guidelines. Include detailed information about the product’s formulation, medicinal ingredients, recommended use, and safety information. Remember to provide evidence supporting your product’s claims and efficacy.

Step 6: Submit Your Application Carefully review your application for accuracy and completeness before submitting it to Health Canada. Pay the required application fee and ensure your submission meets the regulatory requirements.

Step 7: Wait for Review and Approval. Health Canada will review your NPN application, which can take several weeks or months, depending on the complexity of your product. During this process, be prepared for questions or requests for additional information from Health Canada.

Step 8: NPN Issuance Upon successful review and approval, Health Canada will issue your Natural Product Number (NPN). This number must appear on your product label, confirming that it meets Health Canada’s safety and quality standards.

Conclusion: 

Navigating Health Canada’s NPN application process requires meticulous attention to detail and adherence to regulatory standards. By understanding the steps involved and meeting the requirements, you can secure an NPN for your natural health product, gain consumer trust, and contribute to a safer and healthier marketplace for all Canadians. Always stay updated with Health Canada’s regulatory changes to maintain compliance and continue offering your customers safe and effective natural health products.

Categories
Blog News

How to prepare and submit an eStar 510k Submission as of October 1st

Navigating FDA Registration and the 510(k) Process: Your Guide to Getting Your Medical Device to Market

Introduction: 

Staying up-to-date with the latest regulations and tools is crucial in medical device submissions. As of June 9, 2023, the FDA introduced the electronic Submission Template and Resource (eSTAR) for Pre-Submissions, revolutionizing the process for medical device applicants. Starting October 1, 2023, all 510(k) submissions, unless exempted, must be submitted electronically using the eSTAR template. Given this impact on the medical device industry, we’ll answer all your questions about eSTAR in this blog. This article is simply a high-level analysis of the guidance document simplified to give you the most important information broken down but is not a substitute for the full FDA guidance document. 

What Is the eSTAR Template? 

The eSTAR template is your go-to tool for preparing electronic submissions of medical devices, simplifying the process significantly. It’s an interactive PDF form designed to guide applicants through creating a comprehensive submission. With automation features, alignment with FDA review templates, integration of resources, guided section construction, and automatic verification, the eSTAR template streamlines the submission process.

Why Choose eSTAR? 

Aside from it being a requirement eSTAR is available for voluntary use by all medical device applicants, whether you’re submitting 510(k)s, De Novo requests, or Pre-Submissions to the Center for Devices and Radiological Health (CDRH). It’s also applicable for those offering 510(k)s to the Center for Biologics Evaluation and Research (CBER) and combination products.

What Are the Benefits? 

The eSTAR template aims to enhance submission quality by facilitating comprehensive data submission in a standardized format. This ensures completeness, helping the FDA conduct premarket reviews more efficiently. The best part? It reduces the likelihood of your submission undergoing a refuse-to-accept (RTA) process.

How to Get Started with eSTAR:

  • Download the eSTAR PDF template following simple steps.
  • Familiarize yourself with the template’s instructions.
  • Use the template to construct your submission.

Important Tips:

  • Be cautious of file sizes to ensure smooth submission.
  • Combine similar attachments for better organization.
  • You don’t need to include additional forms if you’re using eSTAR.

eSTAR Application Review Process:

  • The FDA conducts a virus scanning and technical screening process for eSTAR submissions.
  • Incomplete eSTAR submissions will be held until completed.
  • Subsequent review processes follow FDA guidelines for substantial equivalence and De Novo classification requests.

How to Submit your eSTAR 510k application: 

Choose from various submission methods, including online through the Electronic Submission Gateway, the CDRH portal, or by mail. Stay updated and make your medical device submissions more efficient with the eSTAR template – your gateway to smoother FDA interactions.

Our experts at Quality Smart Solutions are here to help and offer medical device-related regulatory advice and support on successfully securing your medical device license.  We can help you by responding to potential information requests, keeping your license updated, and reviewing your device labels (510k Medical Device Registration, Facility Registration & FURLS, IVD Device Registration, and SaMD Classification

Frequently Asked Questions about eSTAR

Categories
Blog

Requirements to sell Dietary Supplements in the United States

Discover the essential requirements for selling dietary supplements in the United States. From DSHEA compliance to GMPs and labeling, navigate the regulatory landscape confidently.

You’re about to step into a regulated industry designed to ensure the safety and quality of products. To successfully navigate this space, it’s crucial to understand the requirements and regulations governing the sale of dietary supplements. This article will explore the essential steps and criteria for selling dietary supplement products in the U.S.

1. Understanding Dietary Supplements

Before delving into the requirements, let’s clarify what dietary supplements are. According to the Dietary Supplement Health and Education Act (DSHEA) of 1994, dietary supplements are products intended to supplement the diet. They can include vitamins, minerals, herbs, botanicals, amino acids, enzymes, and other substances.

2. Compliance with DSHEA

The DSHEA serves as the foundational regulatory framework for dietary supplements in the U.S. It sets forth essential requirements that manufacturers and distributors must adhere to:

  • Product Labeling: Dietary supplements must have accurate labeling, including a Supplement Facts panel that provides information about the product’s ingredients and serving size.
  • Ingredient Safety: Manufacturers are responsible for ensuring the safety of ingredients used in their products. They should not include ingredients that are unsafe or unapproved.
  • Claims and Statements: Claims made on dietary supplement labels must be truthful and not misleading. They cannot claim to treat or cure specific diseases.

3. Establishing Good Manufacturing Practices (GMPs)

Manufacturers must follow Good Manufacturing Practices (GMPs) outlined by the U.S. Food and Drug Administration (FDA). These practices ensure that dietary supplements are produced consistently and meet quality standards. GMPs cover various aspects, including facility cleanliness, equipment maintenance, and employee training.

4. Notification to the FDA

While dietary supplements don’t require FDA approval before entering the market, manufacturers must notify the FDA about their products. This notification includes information about the product’s ingredients and labeling. It’s essential to make this notification within 30 days of product launch.

5. Adherence to Dietary Supplement Labeling Requirements

Proper labeling is a cornerstone of dietary supplement compliance. Labels should accurately represent the product’s ingredients, serving size, and claims. It’s crucial to avoid labeling that implies the product is a drug or can cure specific ailments.

6. Avoiding Disease Claims

One critical requirement is the prohibition of disease claims. Dietary supplements cannot claim to diagnose, treat, cure, or prevent diseases. Such claims would categorize the product as a drug, subject to different regulations.

7. Quality Control and Testing

Manufacturers must establish robust quality control systems to ensure their dietary supplements’ identity, purity, strength, and composition. Testing and quality assurance are vital to meeting these requirements.

8. Adverse Event Reporting

Manufacturers and distributors must report serious adverse events associated with their dietary supplements to the FDA. This helps monitor the safety of these products.

9. Compliance with State Regulations

Some states have additional regulations regarding dietary supplements. Ensure compliance with both federal and state requirements.

10. Ongoing Monitoring and Updates

The dietary supplement industry is subject to evolving regulations and ingredient safety evaluations. Stay informed about updates to maintain compliance. Selling dietary supplements in the United States can be a lucrative endeavor. Still, it comes with a responsibility to meet rigorous regulatory standards. By understanding and adhering to these requirements, you can confidently enter the market and offer safe, high-quality products to consumers.

Categories
Blog

A Comprehensive Guide to FSVP Rules and Records for Importers

A Comprehensive Guide to FSVP Rules and Records for Importers Introduction:

Introduction: 

For importers in the global food trade, ensuring the safety and compliance of imported products is a top priority. The Foreign Supplier Verification Program (FSVP) is vital to this effort, requiring importers to adhere to specific rules and meticulously maintain accurate records. In this article, we’ll delve into everything importers need to know about FSVP rules and the crucial role of journals in demonstrating compliance and safeguarding consumer health. Click here to learn more about the FSVP Importer Requirements.

Understanding FSVP Rules

  1. Hazard Analysis: Importers are required to perform a thorough hazard analysis for each imported food product. This involves identifying potential hazards, assessing their likelihood and severity, and determining appropriate preventive measures.
  2. Verification Activities: FSVP rules mandate that importers conduct verification activities to ensure the safety of imported products. These activities include on-site audits, testing, supplier questionnaires, and reviewing supplier records.
  3. Supplier Verification: Importers must verify that their foreign suppliers meet the same safety standards required for domestic food producers. This involves assessing the supplier’s compliance history, safety practices, and product testing.
  4. Documentation and Records: Comprehensive documentation is essential for FSVP compliance. Importers must maintain records that demonstrate their adherence to FSVP rules. This includes hazard analysis documentation, verification results, communication with suppliers, and corrective action plans.

The Crucial Role of FSVP Records

  1. Record-Keeping Requirements: FSVP regulations require importers to maintain records for a specific duration, typically two years. These records must be readily accessible for inspection by regulatory authorities, allowing them to verify compliance.
  2. Transparency and Accountability: Accurate and well-organized records clarify your compliance efforts. In the event of an audit or inspection, thorough records demonstrate your commitment to safety and help build trust with regulatory authorities.
  3. Evidence of Compliance: Records indicate that you have conducted hazard analyses, performed verification activities, and taken necessary corrective actions. This evidence showcases your dedication to product safety.
  4. Corrective Actions: Records of disciplinary actions taken in response to identified hazards or non-compliance demonstrate your commitment to addressing issues promptly and effectively.

Maintaining Effective FSVP Records

  1. Organized Documentation: Create a systematic approach to record-keeping. Maintain digital or physical folders for each imported product, including hazard analyses, verification reports, and supplier communication.
  2. Timely Updates: Ensure records are updated in real-time as you conduct verification activities and identify hazards. Timely updates provide an accurate representation of your compliance efforts.
  3. Regular Reviews: Periodically review your records to identify any gaps or areas for improvement. This proactive approach ensures that your documentation remains comprehensive and accurate.

Conclusion: 

For importers, FSVP rules and records form the backbone of product safety and regulatory compliance. By understanding FSVP rules, diligently maintaining accurate records, and embracing transparency, importers contribute to a safer global food supply chain. Effective record-keeping demonstrates compliance, builds trust with regulatory authorities, and prioritizes consumer health. As importers continue to navigate the intricate landscape of FSVP regulations, comprehensive records are a powerful tool in upholding the highest standards in importing food products.

How Quality Smart Solutions can help

Firstly, QSS can help with formula review, product labeling, and nutrition facts creation (for Canada and the USA).

Secondly, we can also help with registering supplemented foods or reviewing when the new Supplemented Food rules.

Thirdly, we help with Safe Foods for Canadians Regulations (HACCP, PCP, Import Licensing, and GRAS Notifications). 

Help with facility registration, FSVP agent, and US Agent.  Unlock your FSVP Certification with these 7 steps.

Categories
Blog

Inside Scoop: Draft Guidance for MLMD Application Submissions

MLMD Application Submissions

*This summary of Health Canada’s guidance document provides compliance details for manufacturers submitting a new or amended application. Under the regulations, this applies to Class II, III, and IV for MLMD. It does not cover the non-ML information required in a medical device license application.*

Artificial intelligence (AI) encompasses algorithms and models that perform tasks like learning and decision-making. Machine learning (ML) is a subset of AI, where algorithms learn from data to create models. When ML is applied to medical devices, they are called machine learning-enabled medical devices (MLMD), subject to regulations.

“Transparency” means clear information about a device’s impact on risks and patient outcomes, which is crucial for safety and informed decisions.

A predetermined change control plan (PCCP) allows Health Canada to manage planned changes to ML systems addressing known risks. Terms and conditions (T&Cs) may be added to medical device licenses to enhance safety.

Health Canada follows the International Medical Device Regulators Forum (IMDRF) terms. An “ML training algorithm” establishes model parameters from data, the “ML model” makes predictions, and the “ML system” is a medical device with ML capabilities, all regulated by Section 1 of the regulations.

Relevant guidance relating to medical devices, including the following:

Policy Objective:

The policy objective of this guidance is to provide manufacturers with a framework for demonstrating the safety and effectiveness of Machine Learning-Enabled Medical Devices (MLMDs) in various contexts. This guidance applies when manufacturers seek Class II, III, or IV medical device licenses or amend such permits throughout the device lifecycle.

Policy Statements:

  1. MLMD Definition: An MLMD can be standalone software meeting the medical device definition or a medical device incorporating software meeting the definition.
  2. In Vitro Diagnostic Devices (IVDDs): MLMDs can be either IVDDs or non-IVDDs, with risk classifications ranging from Class I to Class IV.
  3. Cover Letter Statements: Manufacturers must explicitly state in their cover letters for Class II, III, and IV MLMD applications that the device employs ML. For MLMDs with a Predetermined Change Control Plan (PCCP), manufacturers must mention the presence of a PCCP in the cover letter to prevent application delays.
  4. Classification Justification: Manufacturers should justify the proposed medical device classification of the MLMD, referring to the classification rules in Schedule 1 of the regulations.
  5. Regulatory Requirements: MLMDs must meet the applicable requirements outlined in sections 10 to 20 of the regulations. Manufacturers must ensure the availability of objective evidence supporting the device’s intended use, safety, effectiveness, and associated claims.
  6. Safety and Effectiveness Assurance: Applications must demonstrate that the MLMD, including the PCCP, if applicable, adheres to safety and effectiveness requirements and maintains a favorable risk-benefit profile for patients.
  7. Application Information: Class II, III, and IV applications must include the information in section 32 of the regulations. Health Canada may request additional information during the review process.
  8. Evidence Consideration: Health Canada recognizes the diversity of information, methodologies, and evidence manufacturers use to establish MLMD safety and effectiveness. The guidance offers considerations rather than fixed requirements to accommodate different scenarios.
  9. Representative Data: Data used by manufacturers should adequately represent the Canadian population and clinical practices, including factors like skin pigmentation, sex differences, and other identity-related variables.
  10. Predetermined Change Control Plan (PCCP): Changes made under an authorized PCCP do not require a separate medical device license amendment application. Such changes remain subject to post-market regulatory oversight.
  11. Amendments Outside PCCP: For modifications outside an authorized PCCP, manufacturers should consult the regulations and relevant guidance to determine if the change constitutes a significant change requiring a license amendment application.
  12. PCCP Submission: Manufacturers may submit a PCCP with applications for new medical device licenses or amendments.
  13. Policy Evolution: This guidance represents Health Canada’s current approach, subject to revision as technology advances and regulatory oversight matures. Health Canada remains adaptable to optimize regulatory practices.

Health Canada MLMD Product Lifecycle Components

Health Canada emphasizes the significance of product lifecycle information in establishing the safety and effectiveness of Machine Learning-Enabled Medical Devices (MLMDs). The MLMD lifecycle comprises several key components, including:

  1. Design: The initial design phase is where the MLMD’s architecture, features, and functionalities are conceptualized and developed.
  2. Risk Management: The assessment and management of risks associated with the MLMD throughout its lifecycle, ensuring patient safety.
  3. Data Selection and Management: The careful selection and effective management of data used in MLMD development and operation is vital for accuracy and reliability.
  4. Development and Training: The process of training ML algorithms, establishing parameters, and refining the ML model to enhance performance.
  5. Testing and Evaluation: Rigorous testing and evaluation to verify the MLMD’s functionality, accuracy, and safety under various conditions.
  6. Clinical Validation: Validation through clinical studies and real-world use to confirm that the MLMD meets its intended medical purpose.
  7. Transparency: Ensuring clear and comprehensive information about the MLMD is available, contributing to informed decision-making.
  8. Post-Market Performance Monitoring: Ongoing monitoring of the MLMD’s performance and safety once it is in the market, including detecting any adverse events or issues.

According to Health Canada’s perspective, these components collectively form the MLMD product lifecycle, which is critical in demonstrating its safety and effectiveness.

Good Machine Learning Practice (GMLP) for MLMDs

Implementing Good Machine Learning Practice (GMLP) is crucial in all Machine Learning-Enabled Medical Device (MLMD) development and maintenance phases. GMLP ensures the creation of safe, effective, and high-quality medical devices.

When applying for an MLMD license, manufacturers should provide evidence of adopting GMLP practices throughout their organization and the product’s lifecycle. This evidence should also include details about quality practices to support changes outlined in a Predetermined Change Control Plan (PCCP).

Predetermined Change Control Plan (PCCP): Concept

A PCCP is a documentation that characterizes the MLMD, its boundaries, intended ML system changes, change management protocols, and impacts. It is an integral part of the device’s design.

PCCPs should be risk-focused, evidence-supported, and provide transparency. They should consider the entire product lifecycle.

Changes listed in a PCCP must ensure the device remains within its intended use. Changes to medical conditions, purposes, or benefits require a separate medical device license amendment application before implementation.

Appropriate changes for inclusion in a PCCP require pre-authorization to address known risks while preserving patient benefits. For instance, changes may aim to maintain or enhance performance, countering the threat of ML performance decline due to environmental alterations or input data variations.

PCCPs facilitate proactive risk management while maintaining rigorous regulatory standards to ensure the safety and effectiveness of the device.

MLMD Risk Management Guidance

Manufacturers are crucial in managing Machine Learning-Enabled Medical Devices (MLMDs) risks. This involves providing descriptions of:

  1. Identified Risks and Controls: Manufacturers should detail the risks linked to the MLMD and the measures to mitigate or eliminate these risks.
  2. Risk Assessment Technique: The method employed for initial and ongoing risk assessments and the system for categorizing and evaluating risk levels.
  3. Risk Assessment Outcomes: The results of the risk assessment process.

The risk analysis should also consider the following factors, where applicable:

  • Erroneous Outputs include instances of false positives, false negatives, or incorrect information used for diagnosis or treatment.
  • Bias: While SGBA Plus analysis may address some intolerance, manufacturers should consider and manage unwanted bias in MLMDs.
  • Overfitting: This issue occurs when a model is overly tailored to specific training examples, making it less applicable to broader problems.
  • Underfitting: When a model doesn’t capture all relevant properties of the training population, resulting in limited applicability.
  • Performance Degradation: ML system performance can decline due to various factors like demographic shifts, changes in clinical practice, or alterations in input data.
  • Automation Bias occurs when users overly rely on device outputs, potentially disregarding contradictory data or human decisions.
  • Alarm Fatigue: Users become desensitized to alarms due to excessive exposure, which can lead to missed alarms.
  • PCCP-Related Risks: Consider risks associated with Predetermined Change Control Plans (PCCPs) and their impacts on risk management.

For comprehensive risk management in MLMDs, manufacturers should refer to ISO 14971, which guides applying risk management to medical devices.

Our experts at Quality Smart Solutions are here to help and offer medical device-related regulatory advice and support on successfully securing your medical device license.  We can help you by responding to potential information requests, keeping your license updated, and reviewing your device labels (510k Medical Device Registration, Facility Registration & FURLS, IVD Device Registration, and SaMD Classification

For more information, click here to read the full guidance document:

Categories
Blog

FSMA Assurance: Safeguarding Food Safety at Every Step

FSMA Assurance

The Food Safety Modernization Act (FSMA) Made Simple

Imagine a world where preventing food-related illnesses is more important than dealing with them after they happen. That’s precisely what the FSMA, introduced in 2011, aims to achieve. The FSMA focuses on stopping contamination and illnesses before they occur, covering various stages of the food supply chain, like production, transportation, and imports. Its main goal is to find and eliminate risks before they become dangerous.

Key Parts of FSMA Safety

  1. Preventive Controls for Human Food (PCHF): This is the heart of FSMA. It says that companies must create plans to keep food safe. These plans include finding possible problems, putting in actions to prevent issues, keeping a close watch, fixing problems, and checking to ensure the method works.
  2. Preventive Controls for Animal Food: This part is like PCHF for animal food. It ensures the same safety principles, including finding hazards, putting controls in place, and watching suppliers.
  3. Foreign Supplier Verification Program (FSVP): Since our food comes from all over the world, this ensures that the food brought into the US is safe. Importers must ensure that foreign suppliers follow the same safety rules as the US.

Meeting FSMA Rules

In a world where following rules keeps us safe, understanding and sticking to FSMA rules is super important. Follow these rules to avoid big problems like fines, recalling products, and hurting your reputation. Here’s how to make sure you’re doing the right thing:

  1. Know What Applies to You: Figure out which FSMA rules matter for what you do. FSMA covers food-related issues, so knowing your role in the food chain is vital.
  2. Plan for Safe Food: A solid plan to keep food safe is necessary. This plan involves looking at possible problems, using smart controls to avoid them, keeping a close eye on things, and ensuring the method works.
  3. Trust Your Suppliers: If you work with suppliers, make sure they’re reliable. Checking them thoroughly helps ensure that what they give you is safe to use.
  4. Teach Your Team: Your team is crucial to keeping food safe. Training them well in safety rules, cleanliness, and their roles in keeping things safe is a must.

How FSMA Consulting Helps

Experts can guide you through the FSMA maze. FSMA consulting services can help you make sense of the rules and give you tailored plans for food safety. They’re great at finding possible problems, making safety plans, and offering ongoing help for following the rules.

To Sum up,

FSMA is all about keeping us healthy. By preventing problems rather than dealing with them later, it makes sure our food is safe. Following FSMA rules isn’t just a formality; it’s about protecting public health and our food supply. Businesses that understand this and work with FSMA experts are leading the way in providing safe, top-quality food to all of us.

Learn more about FSVP Importer requirements and why certification is important in the global supply chain here.

How Quality Smart Solutions can help

Firstly, QSS can help with formula review, product labeling, and nutrition facts creation (for Canada and the USA).

Secondly, we can also help with registering supplemented foods or reviewing when the new Supplemented Food rules.

Thirdly, we help with Safe Foods for Canadians Regulations (HACCP, PCP, Import Licensing, and GRAS Notifications). 

Help with facility registration, FSVP agent, and US Agent.  Unlock your FSVP Certification with these 7 steps.

Categories
Blog

FSVP Planning: Everything you should know before choosing an FSVP Agent for Import/Export

Everything you should know before choosing an FSVP Agent for Import/Export

Introduction: 

In the intricate world of global trade, ensuring the safety and compliance of imported and exported food products is a shared responsibility. The Foreign Supplier Verification Program (FSVP) stands as a cornerstone in this effort, safeguarding the well-being of consumers and the integrity of the food supply chain. When navigating the FSVP landscape, choosing the right FSVP agent is a pivotal decision for both importers and exporters. In this article, we’ll delve into the benefits of partnering with an FSVP agent and provide a list of essential FAQs to ask before making this significant choice. Click here to learn more about the FSVP Importer Requirements.

Benefits of Choosing an FSVP Agent:

  1. Expertise and Compliance: An experienced FSVP agent possesses in-depth knowledge of FSVP regulations. By partnering with an agent, importers and exporters ensure full compliance with the requirements.
  2. Tailored Solutions: Each business has unique operations and needs. An FSVP agent crafts personalized solutions that align with the specific nature of your imports or exports, streamlining the compliance process.
  3. Navigating Complexities: FSVP regulations can be complex and subject to updates. An FSVP agent constantly monitors changes, keeping you informed and helping you adapt to evolving compliance standards.
  4. Audit Readiness: Regular audits are part of FSVP compliance. A seasoned FSVP agent prepares your business for audits, ensuring all documentation and processes are audit-ready.
  5. Risk Assessment: Identifying potential hazards and risks is vital. An FSVP agent conducts thorough risk assessments, guiding you in prioritizing mitigation efforts and enhancing product safety.

FAQs to Ask Before Choosing an FSVP Agent:

  1. What is Your Experience with FSVP Compliance? Please inquire about the agent’s background and expertise in FSVP regulations to ensure a strong track record.
  2. How Will You Tailor Compliance Strategies to My Business? Understanding how the agent customizes solutions to your unique needs ensures effective compliance.
  3. What Tools and Resources Do You Provide for Record-Keeping? Comprehensive record-keeping is crucial. Ask about the tools and support they offer to maintain accurate records.
  4. How Do You Stay Updated with Regulatory Changes? To keep your business compliant, an agent should have a straightforward process for staying informed about FSVP regulation updates.
  5. Can You Provide References or Case Studies? Request references or case studies to gauge their success in assisting businesses like yours.
  6. What Support Do You Offer During Audits? Ensuring the agent assists during audits provides a smoother experience when regulatory authorities review your operations.
  7. What is Your Approach to Risk Assessment? Understanding their risk assessment process highlights their dedication to product safety.

Ten steps to creating an FSVP plan

Step 1: Understand FSVP Requirements: Before diving into implementation, familiarize yourself with the FSVP requirements outlined by the U.S. Food and Drug Administration (FDA). Gain a clear understanding of your responsibilities, including conducting hazard analyses, supplier verification, record-keeping, and corrective actions.

Step 2: Identify Applicable Foreign Suppliers: Compile a list of foreign suppliers who provide food products to your business. Prioritize suppliers based on the risk level associated with their products and ensure you have access to their necessary information.

Step 3: Conduct a Hazard Analysis: Evaluate potential hazards associated with each imported food product. Consider biological, chemical, and physical risks during production, transportation, and handling.

Step 4: Determine Verification Activities: Based on the hazard analysis, identify appropriate verification activities to ensure the safety of imported products. These activities may include on-site audits, sampling and testing, supplier questionnaires, and documentation reviews.

Step 5: Develop a Supplier Verification Program: Craft a comprehensive supplier verification program outlining each supplier’s specific verification activities. This program should detail the frequency of verifications, criteria for approval, and any corrective actions required.

Step 6: Establish Record-Keeping Procedures: Maintain meticulous records of your FSVP activities: document hazard analyses, verification results, corrective actions, and communication with suppliers. Ensure records are organized, easily accessible, and retained for the required timeframe.

Step 7: Implement Corrective Actions: In cases where hazards are identified, or verification activities uncover non-compliance, take prompt corrective actions. These actions should address the root cause of the issue and prevent its recurrence.

Step 8: Provide Supplier Training: Educate your foreign suppliers about FSVP requirements and the importance of compliance. Offer guidance on meeting safety standards and providing necessary documentation.

Step 9: Review and Update Your FSVP Plan: Regularly review and update your FSVP plan to ensure it remains effective and aligned with changing regulations. Conduct internal audits to assess the plan’s implementation and identify improvement areas.

Step 10: Seek Expert Assistance: Navigating the complexities of FSVP implementation can be daunting. Consider partnering with regulatory consultants who specialize in FSVP compliance. These experts provide invaluable guidance, ensuring your plan is comprehensive and compliant.

Conclusion: 

Selecting the right FSVP agent is a pivotal choice for importers and exporters, impacting compliance, safety, and the success of their businesses. With the benefits of expertise, tailored solutions, and audit readiness, an FSVP agent becomes a trusted partner in navigating the regulatory landscape. By posing crucial questions about compliance strategies, resources, and support, businesses can make an informed decision, confident that their chosen FSVP agent will guide them toward maintaining the highest standards in the global food trade.

How Quality Smart Solutions can help

Firstly, QSS can help with formula review, product labeling, and nutrition facts creation (for Canada and the USA).

Secondly, we can also help with registering supplemented foods or reviewing when the new Supplemented Food rules.

Thirdly, we help with Safe Foods for Canadians Regulations (HACCP, PCP, Import Licensing, and GRAS Notifications). 

Help with facility registration, FSVP agent, and US Agent.  Unlock your FSVP Certification with these 7 steps.

Categories
Blog

Staying Ahead of the Game: Key Insights on the Latest Requirements for New Drug Submissions

New Drug Submissions

 

From FDA guidelines to global regulatory standards, understanding the nuances of each requirement is essential to ensure a timely and successful drug submission. Our experts have analyzed the latest updates and compiled a comprehensive guide to help you stay ahead of the curve.

In the dynamic and highly regulated world of pharmaceuticals, staying ahead of the game is not just a competitive advantage; it’s a necessity. Understanding the latest requirements for new drug submissions is essential for pharmaceutical companies seeking to bring new drugs to market. This article delves into the key insights that can keep your drug development process on track and compliant with evolving regulations while highlighting the substantial benefits of investing in new drug submissions. Check out our dedicated page for ANDS and NDS submissions for more information.

The Evolving Landscape of New Drug Submissions

The landscape of new drug submissions is continuously evolving. Regulatory authorities such as the U.S. Food and Drug Administration (FDA), the European Medicines Agency (EMA), and others worldwide regularly update their guidelines and requirements. Staying informed about these changes is paramount, allowing pharmaceutical companies to adapt swiftly and ensure their submissions meet the latest standards.

Navigating the Regulatory Maze: A Worthwhile Investment

One of the first steps in preparing a new drug submission is identifying your product’s specific regulatory pathway. Different types of drugs (e.g., small molecules, biologics, generics) often follow distinct regulatory routes. Understanding which path your prescription falls under is crucial to meeting the correct submission requirements.

Investing in a well-versed regulatory affairs team or partnering with experts in the field can streamline this process. Pharmaceutical companies can confidently avoid costly delays and navigate the regulatory maze by doing so.

Quality Data Is King: Ensuring Successful Approvals

The quality of the data submitted is a cornerstone of a successful new drug submission. Rigorous testing and documentation of the drug’s safety, efficacy, and manufacturing processes are paramount. The FDA and other regulatory bodies emphasize the importance of comprehensive and well-organized data to support a submission.

Investing in robust data collection, analysis, and documentation processes is not just a regulatory requirement; it’s a strategic investment in the success of your drug. A well-prepared submission can increase the likelihood of timely approvals and market access.

Benefit-Risk Assessment: A Strategic Advantage

Assessing the benefit-risk profile of your drug is a central focus for regulatory authorities. It would be best to thoroughly analyze the drug’s benefits compared to its potential risks. A well-structured benefit-risk assessment can make a difference in the approval of your submission.

Investing in comprehensive benefit-risk assessments during drug development can enhance your product’s competitive edge. By proactively addressing potential risks and demonstrating superior benefits, your drug stands a better chance of receiving regulatory approval.

Patient-Centricity and Real-World Data: Gaining Market Advantage

Regulatory agencies increasingly value patient-centric approaches and real-world data in assessing drug submissions. Demonstrating how your drug meets patients’ needs and leveraging real-world evidence can strengthen your proposal.

Investing in patient engagement and real-world data collection aligns with regulatory expectations. It resonates with healthcare providers, payers, and patients. It can differentiate your product in the market and accelerate its adoption.

New Drug Submissions

Global Harmonization: Expanding Market Reach

Global harmonization initiatives aim to align regulatory requirements across different regions. Understanding and navigating these harmonization efforts can simplify the submission process for drugs intended for multiple markets.

Investing in a global regulatory strategy can maximize market reach and profitability. By aligning submissions with international standards, pharmaceutical companies can reduce duplication of efforts and capitalize on larger patient populations.

Digital Submissions and eCTD: Efficiency and Compliance

The move toward electronic Common Technical Document (eCTD) submissions is becoming more prevalent. Familiarizing yourself with eCTD formats and requirements is crucial for a smooth submission process.

Investing in digital submission capabilities enhances efficiency and compliance. It streamlines document management, accelerates review processes, and reduces the risk of errors.

Post-Submission Interaction: Collaboration Yields Success

The interaction between the pharmaceutical company and regulatory authorities continues after submission. Engaging in a collaborative dialogue and promptly addressing questions and concerns raised during the review process can significantly impact the outcome.

Investing in effective communication and a responsive regulatory affairs team can lead to faster approvals and a more favorable regulatory relationship.

Conclusion: A Sound Investment in Patient Health and Market Success

In conclusion, new drug submissions are not just a regulatory requirement; they represent a sound investment in patient health and market success. By staying informed, prepared, and flexible, pharmaceutical companies can successfully navigate the complex world of drug submissions. The benefits include expedited market access, enhanced competitiveness, and, most importantly, the opportunity to bring life-changing therapies to needy patients. As the pharmaceutical landscape evolves, those who invest wisely in new drug submissions stand to reap the rewards of innovation and impact.

Categories
Blog

Demystifying GHP and GMP Regulatory Food Safety Audits: Why They Matter

In the realm of food production and processing, safety is paramount. Ensuring our food is free from contaminants and meets stringent quality standards is a shared responsibility. This is where Good Hygiene Practices (GHP) and Good Manufacturing Practices (GMP) come into play. This comprehensive guide will explore the significance of GHP and GMP regulatory food safety audits. We’ll uncover why these audits are crucial and how they contribute to safeguarding the integrity of our food supply. We’ll help you unpack everything to do with food regulations.

Food Safety Audits

Understanding GHP and GMP: The Foundation of Food Safety

GHP (Good Hygiene Practices): GHP focuses on the cleanliness and hygiene of facilities and personnel involved in food handling and production. It encompasses a wide range of practices, including proper handwashing, sanitation of equipment, safe food storage, and maintaining hygienic working conditions. GHP lays the foundation for safe food handling from farm to fork.

GHP includes practices such as:

  1. Personal Hygiene: Ensuring that food handlers maintain cleanliness through proper handwashing, wearing suitable protective clothing, and minimizing the risk of contamination.
  2. Sanitization: Regular cleaning and sanitizing of equipment, utensils, and food preparation surfaces to prevent the growth of harmful bacteria.
  3. Safe Food Storage: Proper storage conditions to prevent spoilage and contamination of food products.
  4. Waste Management: Proper disposal of food waste and other materials to prevent pests and cross-contamination.

Good Hygiene Practice, or GHP, is a critical element in managing food chain hygiene along the entire food supply chain and ensuring that the food is secure and fit for consumption. It deals with many facets of the food industry, such as physical and chemical pollution control, worker hygiene, sanitary facilities, and the food supply chain. It is frequently required for other food safety management programs, including HACCP, ISO 2200, GAP, etc.

The essential hygienic and sanitary procedures are covered by GHP compliance. It draws attention to problem areas and possible roadblocks to raising your standards for food safety. Your workplaces, equipment, and facilities will be examined throughout the audit to identify potential hazards and areas that need improvement. It will assess and ensure that the food being processed is suitable for human consumption and is the bare minimum required to comply with regulations in the industry for hotels and restaurants. Food contamination and disease should not be taken lightly; GHP compliance will aid in that consideration.

What is the purpose of GHP in Food Safety?

The purpose of GHP is to:

  1. Minimize Health Risks: GHP practices reduce the risk of foodborne illnesses by preventing contamination at every stage of food production and handling.
  2. Maintain Product Quality: By adhering to GHP, businesses ensure that their products meet quality standards and are safe for consumption.
  3. Compliance: GHP helps businesses comply with food safety regulations and standards, avoiding legal issues and penalties.

GMP (Good Manufacturing Practices): GMP deals with the specific processes and procedures used to manufacture and process food products. It ensures that products are consistently produced and controlled to meet quality standards. GMP covers aspects like ingredient sourcing, equipment maintenance, and product testing.

What Are the Good Manufacturing Practices (GMP) in the Food Industry?

GMP in the food industry includes:

  1. Quality Control: Implementing measures to maintain product quality throughout the production process.
  2. Documentation: Keeping detailed records of production processes, ingredient sources, and quality control measures.
  3. Employee Training: Ensuring that staff is adequately trained in GMP procedures.

What Are the 10 Principles of GMP?

Nevertheless, the GMP guidelines can change based on the area of the food processing industry.

They consist of ten fundamental GMP guidelines that all food producers must adhere to:

  1. Standard Operating Procedures (SOPs) should be written in step-by-step format.
  2. Apply the SOPs and procedures.
  3. For the aim of traceability, promptly and precisely document processes and procedures.
  4. Verify the efficiency of your SOPs and the efficacy of your procedures.
  5. Integrate quality and safety into the equipment and facilities.
  6. Regularly maintain the building, its systems, and its equipment, and keep records of it.
  7. Internally establish job competency.
  8. Encourage cleanliness by performing regular sanitization.
  9. Implement a methodical quality control for both the components and the processes.
  10. To maintain legal compliance and GMP efficacy, conduct routine audits.

Conclusion: 

GHP and GMP regulatory food safety audits are not just routine procedures; they are the backbone of a safe and reliable food supply chain. By adhering to these practices and undergoing audits, businesses ensure that their food is of the highest quality and, most importantly, safe for consumers. The importance of these audits cannot be overstated, as they are instrumental in protecting public health and maintaining the integrity of the food industry.

How can Quality Smart Solutions serve you?

Firstly, QSS can help with formula review, product labeling, and nutrition facts creation (for Canada and the USA).

Secondly, we can also help with registering supplemented foods with TMALs (Temporary Market Authorization License) or reviewing when the new Supplemented Food Regulations are published. 

Thirdly, we help with Safe Foods for Canadians Regulations (HACCP, PCP, Import Licensing, and GRAS Notifications). 

Help with facility registration, FSVP agent, and US Agent. 

Check out this blog on why Food Certifications are so important.

Subscribe to global regulatory updates

We use cookies to display personalized content, analyze site traffic, provide recommendations, and ensure you have a great browsing experience. By continuing to use our site, you consent to our use of cookies. Privacy Policy.